A 69-year-old male was admitted following recurrent syncope in the presence of a bifascicular block and mildly elevated Troponin-I levels (157 ng/L). Echocardiography demonstrated severe left ventricular hypertrophy. A stress CMR for ischaemia and to assess for hypertrophic cardiomyopathy was requested after implantation of an MRI-safe pacemaker due to the risk of asystole with adenosine. A Medtronic Ensura TM pacemaker was implanted in the right deltopectoral groove to minimize metallic artefacts over the heart. CMR performed on a 1.5 T scanner (Avanto TM , Siemens, Germany) with the pacemaker programmed to DOO confirmed hypertrophic cardiomyopathy. Standard CMR sequences were undertaken with artefact absent apart from a small area of non-significant signal loss (susceptibility artefact) in the right ventricular cavity due to the pacing lead. All images were of good quality and superior to the degraded images produced on a recent patient with an identical left-sided implant (Panels F -H). The patient has had no limitation of function related to device implantation.
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Where a pacemaker or implantable defibrillator is required before CMR, we recommend right-sided implantation to minimize cardiac artefacts.
Images from the patients with left-and right-sided pacemakers (artefacts labelled with white arrows). Both patients had identical right atrial and right ventricular apex lead/electrode positions. Top row (left-sided), left to right: (A) chest X-ray. (B) two-chamber steady-state free precession (SSFP) CMR cine with distortion over anterior wall and apex. (C ) Two-chamber LGE CMR sequence with distortion artefact over basal to mid-anterior wall. (D) Short-axis LGE CMR sequence demonstrating severe distortion artefact. Bottom row (right-sided). (E) Chest X-ray. (F ) Two-chamber SSFP cine with no artefact, despite using SSFP, which is particularly prone to metallic artefacts. (G) Two-chamber LGE and with no artefact; patchy fibrosis associated with HCM seen in inferior wall (labelled asterisk). (H ) Short-axis LGE with no artefact; fibrosis in septum and anterior wall (labelled asterisk).
